PPT-Cancer and Hematology Clinical Research Program

a nd Translational Research Core About the CHCRP Founded in 1991 Cancer and Hematologybased Trials Cancer Treatment Prevention or Early Detection Symptom Management symptoms caused by disease or by treatments. Cancer: Brain Tumors. Charles . Cobbs. , MD; . Liliana. . Soroceanu. , MD, PhD. . Cancer: Culturing Cells for Targeted Breast Cancer Drug Development. Shanaz. . Dairkee. , PhD. Cancer: Breast Cancer Disease Progression. Site Specific Group Meeting. Tuesday 10th February 2015. Maxine Taylor. Senior Research Delivery Manager. Content of report. Overview of network changes. Overview of research activity. New studies for the portfolio. Associate Director for Administration. 2015 CCAF Meeting . Lexington Kentucky. UC San Diego Health System/. Moores Cancer Center Synergies. 1. . Major Hospital/CC Intersections. . Facilities. . Clinical Trials. Maribelis Ruiz, PhD. Maribelis.ruiz@bms.com. May 13, 2011. Outline. Introduction – my career track. Successful Transitions: Lessons learned. Managing your career. My Career Track. Medical Science Liaison. . Primary Instructor: . Elizabeth Garrett-Mayer, PhD. Professor of Biostatistics, Dept. of Public Health Sciences. Director of Biostatistics, Hollings Cancer Center. Context: K-12 award. Paul . Calabresi. Shannon Benson, RN, MSN. Administrator. Iowa-Wide Oncology Research Coalition . Who is I-WORC?. Iowa Oncology Research Association. Funded by the National Cancer Institute . Established in 1978. 8 Sites: Des Moines, Blank, Mason City, Ames, Cedar Rapids x 2, Ottumwa, Moline. UNC and Chapel Hill. UNC. Oldest public university in the US. NCI-ranked “Exceptional” Comprehensive Cancer Center . Gillings. School of Public Health (#2 in U.S.). Eshelman. School of Pharmacy (#1 in U.S.). Alice J. Cohen, M.D., F.A.C.P.. Newark Beth Israel Medical Center. Associate Clinical Professor of Medicine. Rutgers - New Jersey Medical School. Newark, NJ. Disclosures. None. Scope of the Problem. Antonius Schuh, Ph.D. | . Chief Executive Officer. September . 2013. Forward-Looking Statements. Statements in this presentation about the Company's expectations, applications of its technology, markets, launch of tests and other statements that are not historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on management's current beliefs, assumptions, estimates and projections. Actual results may differ materially from those projected in the forward-looking statements for various reasons, including risks associated with product and test development, test transfer to contracting labs, government regulation, market acceptance, limited commercial experience, dependence on key personnel, obtaining financing and other factors discussed in the Company's periodic reports filed with the Securities and Exchange Commission.. Achievements and Next Steps to Tackle Cancer Grand Challenges . An update for . Faculty of Medicine Retreat. December 2017. Cancer Research Continuum . Basic research is the foundation on which the cancer research continuum is built.. Welcome to the Oncology Clinic In the following pages, we will help you with: hat to expect at your first visit ow to get to the Hematology/Oncology Clinicow to make the most of your appointmentWe Pediatric Hematology/Oncology Prepared by The American Society of Pediatric Hematology/Oncology ASPHO 8735 W. Higgins Rd., Suite 300, Chicago, IL 60631 847.375.4716 aspho.org ABOUT ASPHO The America What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T his pamphlet answers these and other frequent questions - Oncology The Tata Group has always believed in returning wealth to the Society it serves. It has established philanthropic trusts which have created National Institutions in Science and Technology